T&L Co., Ltd. (KOSDAQ:340570)
58,200
-1,000 (-1.69%)
Jun 12, 2026, 3:30 PM KST
T&L Co., Ltd. Revenue
T&L Co., Ltd. had revenue of 45.07B KRW in the quarter ending March 31, 2026, a decrease of -12.18%. This brings the company's revenue in the last twelve months to 157.91B, down -21.59% year-over-year. In the year 2025, T&L Co., Ltd. had annual revenue of 164.16B, down -6.14%.
Revenue (ttm)
157.91B
Revenue Growth
-21.59%
P/S Ratio
2.95
Revenue / Employee
652.51M
Employees
242
Market Cap
466.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 164.16B | -10.73B | -6.14% |
| Dec 31, 2024 | 174.89B | 59.43B | 51.47% |
| Dec 31, 2023 | 115.46B | 33.88B | 41.54% |
| Dec 31, 2022 | 81.58B | 9.68B | 13.47% |
| Dec 31, 2021 | 71.90B | 31.26B | 76.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 718.78B |
| Value Added Technology | 430.30B |
| CLASSYS | 346.88B |
| Vieworks | 243.11B |
| BioNote | 122.44B |
| Dongbang Medical | 117.37B |
| Shinhung | 104.15B |
| PCL, Inc. | 4.98B |